Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Multi-Center, Randomized, Parallel-Group Study to Assess the Efficacy and Safety of 400 mg of Velneperit (S-2367) and 120 mg of Orlistat Administered Individually or Combined Orally Three Times Per Day With a Reduced Calorie Diet (RCD) in Obese Subjects

NCT01126970 is registered in ClinicalTrials.gov with Shionogi as lead sponsor.

NCT NCT01126970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01126970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Multi-Center, Randomized, Parallel-Group Study to Assess the Efficacy and Safety of 400 mg of Velneperit (S-2367) and 120 mg of Orlistat Administered Individually or Combined Orally Three Times Per Day With a Reduced Calorie Diet (RCD) in Obese Subjects
Lead sponsor
Shionogi
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2010
Completion date
February 28, 2011
Enrollment
486 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

obesity